Directorate Change

Spire Healthcare Group plc

("Spire Healthcare")

Board Change

2 March 2018

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, today announces that after 7 years as Chief Financial Officer (CFO) at Spire, Simon Gordon stepped down as an Executive Director of the Company on 1 March 2018. His successor will be announced in due course. Simon will remain with the Company until 31 March 2018.

Garry Watts, Spire's Chairman, said: "The Board is grateful to Simon for his many significant contributions to Spire since joining the Company in 2011, including the Initial Public Offering in July 2014 and his taking on the role of Interim Chief Executive in 2017. We wish him well for the future."

Justin Ash, Spire's CEO, commented: "I would like to add my personal thanks to Simon for all his support and assistance to me since I joined the Company in October 2017. The initiatives he introduced as CFO and latterly as Interim CEO have laid the foundation for the evolving strategy and vision for Spire that we intend to pursue. "

Simon Gordon said: "Although from time to time challenging, I have thoroughly enjoyed my time at Spire and with Justin's appointment as CEO I feel that I can now move on to my next challenge. I am sure the Company will prosper under his leadership."

There are no further disclosures to be made under rule 9.6.13 of the Listing Rules.

The Company has today made its preliminary announcement of the 2017 full year financial results which also contains guidance for the 2018 full financial year.

For further information please contact:

Spire Healthcare

Antony Mannion, Investor Relations Director +44 (0)20 7427 9160

Maitland

Sam Turvey +44 (0)20 7379 5151

Jason Ochere